Pharmacy College Collaborates With Educators From Japan

In the continued effort to extend their global reach, the administration and faculty at the James L. Winkle College of Pharmacy recently hosted health care professionals from the Health Professional Development Center at the Chiba University Hospital in Chiba, Japan.

The visitors, Daniel Salcedo, MD, and Tomoko Yamado-Inagawa, PhD, were at UC for four days to observe the Academic Health Center’s best practices for multi-cultural awareness.  Two representatives from Winkle College of Pharmacy acted as hosts: associate professor Alex Lin, PhD, and Pat Achoe, MBA, RPh, Director of Equity and Inclusion.

Lin and Achoe assisted the visitors with the development of a multicultural competency program.

"This visit, along with our other activities this year, align with our goal of expanding our global footprint as a college, " says Neil MacKinnon, PhD, Dean of the Winkle College of Pharmacy. "We are developing deep and ongoing partnerships with select universities and hospitals in select parts of the globe.”

In September, the college signed agreements with two universities in China for collaborative academic programs in cosmetic science and drug development and also sent the first cohort of PharmD students to Chile for a study abroad experience. New study abroad opportunities for PharmD students are being developed in 2018 in Scotland and Italy. 

Tags

Related Stories

2

Health care industry is hiring despite a job market that has cooled

April 16, 2026

The US labor market has cooled but the demand for health care workers, expecially skilled nurses, remains strong. Interviews with UC College of Nursing admininstrators Dr. Donna Green and Dr. Lindsay Davis were part of a WCPO segment on health care industry hiring.

3

AI advances in the liver disease field

April 15, 2026

MASH represents the advanced inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease), where fat accumulation in the liver triggers fibrosis and progressive liver injury. According to a recent MedCentral article, more AI-based clinical assessment tools in MASH are needed.